Cargando…
Early COVID-Related pandemic impacts and subsequent opioid outcomes among persons receiving medication for opioid use disorder: a secondary data analysis of a Type-3 hybrid trial
BACKGROUND: Opioid overdoses have continued to increase since the start of the COVID-19 pandemic. The pathways through which the COVID-19 pandemic has affected trajectories of opioid use and opioid-related problems are largely unknown. Using the Epidemic-Pandemic Impacts Inventory (EPII), a novel in...
Autores principales: | Janssen, Tim, Garner, Bryan R., Yermash, Julia, Yap, Kimberly R., Becker, Sara J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10500804/ https://www.ncbi.nlm.nih.gov/pubmed/37705105 http://dx.doi.org/10.1186/s13722-023-00409-7 |
Ejemplares similares
-
Impacts of the COVID-19 pandemic on healthcare access among patients receiving medication for opioid use disorder
por: Jacka, Brendan P., et al.
Publicado: (2021) -
Persons from racial and ethnic minority groups receiving medication for opioid use disorder experienced increased difficulty accessing harm reduction services during COVID-19
por: Rosales, Robert, et al.
Publicado: (2022) -
Examining Changes in Pain Interference via Pandemic-Induced Isolation Among Patients Receiving Medication for Opioid Use Disorder: A Secondary Data Analysis
por: Frohe, Tessa, et al.
Publicado: (2023) -
Sustainment of contingency management within opioid treatment programs: COVID-related barriers and innovative workflow adaptations
por: Becker, Sara J., et al.
Publicado: (2021) -
Implementing contingency management for stimulant use in opioid treatment programs: protocol of a type III hybrid effectiveness-stepped-wedge trial
por: Becker, Sara J., et al.
Publicado: (2023)